ATE209206T1 - Heterocyclisch substituierte cyclopentanderivate. - Google Patents
Heterocyclisch substituierte cyclopentanderivate.Info
- Publication number
- ATE209206T1 ATE209206T1 AT96918151T AT96918151T ATE209206T1 AT E209206 T1 ATE209206 T1 AT E209206T1 AT 96918151 T AT96918151 T AT 96918151T AT 96918151 T AT96918151 T AT 96918151T AT E209206 T1 ATE209206 T1 AT E209206T1
- Authority
- AT
- Austria
- Prior art keywords
- derivatives
- heterocyclic substituted
- compounds
- cyclopentan
- substituted cyclopentan
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47248695A | 1995-06-07 | 1995-06-07 | |
US08/651,882 US6143749A (en) | 1995-06-07 | 1996-06-04 | Heterocyclic substituted cyclopentane compounds |
PCT/US1996/009042 WO1996040686A1 (en) | 1995-06-07 | 1996-06-06 | Heterocyclic substituted cyclopentane compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE209206T1 true ATE209206T1 (de) | 2001-12-15 |
Family
ID=27043790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96918151T ATE209206T1 (de) | 1995-06-07 | 1996-06-06 | Heterocyclisch substituierte cyclopentanderivate. |
Country Status (11)
Country | Link |
---|---|
US (1) | US6143749A (de) |
EP (1) | EP0873340B1 (de) |
JP (1) | JP2000501694A (de) |
AT (1) | ATE209206T1 (de) |
CA (1) | CA2220006A1 (de) |
DE (1) | DE69617273T2 (de) |
DK (1) | DK0873340T3 (de) |
ES (1) | ES2168479T3 (de) |
MX (1) | MX9709718A (de) |
PT (1) | PT873340E (de) |
WO (1) | WO1996040686A1 (de) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5721356A (en) * | 1989-09-15 | 1998-02-24 | Gensia, Inc. | Orally active adenosine kinase inhibitors |
US5674998A (en) * | 1989-09-15 | 1997-10-07 | Gensia Inc. | C-4' modified adenosine kinase inhibitors |
CH690773A5 (de) * | 1996-02-01 | 2001-01-15 | Novartis Ag | Pyrrolo(2,3-d)pyrimide und ihre Verwendung. |
GB9704948D0 (en) | 1997-03-11 | 1997-04-30 | Knoll Ag | Therapeutic agents |
ID24653A (id) * | 1997-03-19 | 2000-07-27 | Basf Ag | Zat-zat terapi |
US7863444B2 (en) | 1997-03-19 | 2011-01-04 | Abbott Laboratories | 4-aminopyrrolopyrimidines as kinase inhibitors |
IL131618A0 (en) * | 1997-04-16 | 2001-01-28 | Abbott Lab | 5,7-Disubstituted aminopyrido [2,3-D] pyrimidine compounds and their use as adenosine kinase inhibitors |
JP2002526500A (ja) * | 1998-09-18 | 2002-08-20 | ビーエーエスエフ アクチェンゲゼルシャフト | プロテインキナーゼ阻害剤としてのピロロピリミジン |
US6713474B2 (en) | 1998-09-18 | 2004-03-30 | Abbott Gmbh & Co. Kg | Pyrrolopyrimidines as therapeutic agents |
TWI229674B (en) | 1998-12-04 | 2005-03-21 | Astra Pharma Prod | Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses |
US7071199B1 (en) | 1999-09-17 | 2006-07-04 | Abbott Gmbh & Cco. Kg | Kinase inhibitors as therapeutic agents |
AU2000240570A1 (en) * | 2000-03-29 | 2001-10-08 | Knoll Gesellschaft Mit Beschraenkter Haftung | Pyrrolopyrimidines as tyrosine kinase inhibitors |
GB0128885D0 (en) * | 2001-12-03 | 2002-01-23 | Merck Sharp & Dohme | Therapeutic agents |
US7169918B2 (en) * | 2003-10-27 | 2007-01-30 | Genelabs Technologies, Inc. | Methods for preparing 7-(2′-substituted-β-D-ribofuranosyl)-4-(NR2R3)-5-(substituted ethyn-1-yl)-pyrrolo[2,3-d]pyrimidine derivatives |
US7345034B2 (en) * | 2004-04-07 | 2008-03-18 | Abbott Laboratories | Azacyclosteroid histamine-3 receptor ligands |
GT200500281A (es) * | 2004-10-22 | 2006-04-24 | Novartis Ag | Compuestos organicos. |
EP1981890A2 (de) * | 2006-01-25 | 2008-10-22 | OSI Pharmaceuticals, Inc. | UNGESÄTTIGTE mTOR-HEMMER |
PT2013211E (pt) * | 2006-04-21 | 2012-06-21 | Novartis Ag | Derivados de purina para utilização como agonistas de receptores a2a de adenosina |
BRPI0819799A2 (pt) * | 2007-11-23 | 2015-05-26 | Leo Pharma As | Composto, intermediário, uso de um composto, composição farmacêutica, e, método para prevenir, tratar ou melhorar uma doença |
GB201004311D0 (en) * | 2010-03-15 | 2010-04-28 | Proximagen Ltd | New enzyme inhibitor compounds |
GB201115853D0 (en) * | 2011-09-14 | 2011-10-26 | Proximagen Ltd | New enzyme inhibitor compounds |
IN2014DN01883A (de) * | 2011-09-14 | 2015-05-15 | Proximagen Ltd | |
ES2646019T3 (es) | 2013-05-14 | 2017-12-11 | Nerviano Medical Sciences S.R.L. | Derivados de 6-amino-7-deaza-purina, proceso para su preparación y su uso como inhibidores de cinasa |
TW202321249A (zh) | 2015-08-26 | 2023-06-01 | 比利時商健生藥品公司 | 使用作為prmt5抑制劑之新穎經6-6雙環芳香環取代之核苷類似物 |
MA41559A (fr) | 2015-09-08 | 2017-12-26 | Taiho Pharmaceutical Co Ltd | Composé de pyrimidine condensé ou un sel de celui-ci |
PT3269370T (pt) | 2016-02-23 | 2020-03-05 | Taiho Pharmaceutical Co Ltd | Novo composto de pirimidina condensada ou sal do mesmo |
EA201892031A1 (ru) | 2016-03-10 | 2019-02-28 | Янссен Фармацевтика Нв | Замещенные аналоги нуклеозидов для применения в качестве ингибиторов prmt5 |
CA2969295A1 (en) * | 2016-06-06 | 2017-12-06 | Pfizer Inc. | Substituted carbonucleoside derivatives, and use thereof as a prmt5 inhibitor |
MA46228A (fr) | 2016-09-14 | 2019-07-24 | Janssen Pharmaceutica Nv | Inhibiteurs bicycliques fusionnés de l'interaction ménine-mll |
CN109689663B (zh) | 2016-09-14 | 2023-04-14 | 詹森药业有限公司 | Menin-mll相互作用的螺二环抑制剂 |
MX2019003843A (es) * | 2016-10-03 | 2019-06-24 | Janssen Pharmaceutica Nv | Análogos novedosos de carbanucleósidos sustituidos de sistema anular monocíclico y bicíclico para su uso como inhibidores de prmt5. |
US10745409B2 (en) | 2016-12-15 | 2020-08-18 | Janssen Pharmaceutica Nv | Azepane inhibitors of menin-MLL interaction |
EA201990851A1 (ru) | 2017-02-24 | 2019-09-30 | Янссен Фармацевтика Нв | Новые аналоги карбануклеозида, замещенные моноциклической и бициклической кольцевой системой, для применения в качестве ингибиторов prmt5 |
UA127679C2 (uk) | 2017-02-27 | 2023-11-29 | Янссен Фармацевтика Нв | Спосіб ідентифікації пацієнта, що характеризується наявністю сприйнятливості до лікування недрібноклітинного раку легені інгібітором prmt5 |
WO2018160824A1 (en) * | 2017-03-01 | 2018-09-07 | Prelude Therapeutics, Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
CA3084449A1 (en) | 2017-12-08 | 2019-06-13 | Janssen Pharmaceutica Nv | Novel spirobicyclic analogues |
US11396517B1 (en) | 2017-12-20 | 2022-07-26 | Janssen Pharmaceutica Nv | Exo-aza spiro inhibitors of menin-MLL interaction |
KR20220023330A (ko) * | 2019-03-25 | 2022-03-02 | 캘리포니아 인스티튜트 오브 테크놀로지 | Prmt5 억제제 및 이의 용도 |
TW202112375A (zh) | 2019-06-06 | 2021-04-01 | 比利時商健生藥品公司 | 使用prmt5抑制劑治療癌症之方法 |
PE20220433A1 (es) | 2019-06-12 | 2022-03-29 | Janssen Pharmaceutica Nv | Intermedios espirobiciclicos novedosos |
CN111320634A (zh) * | 2020-04-14 | 2020-06-23 | 浙江工业大学 | 一种乙酰氧取代的吡咯并[2,3-d]嘧啶衍生物的制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3551428A (en) * | 1956-02-10 | 1970-12-29 | Ciba Geigy Corp | New 1- (or 2-) substituted 4-mercapto-pyrazolo(3,4-d)pyrimidines |
US3311628A (en) * | 1965-03-09 | 1967-03-28 | Bristol Myers Co | Derivatives of pyrrolo [2, 3-d] pyrimidine |
US3296261A (en) * | 1965-03-09 | 1967-01-03 | Bristol Myers Co | 6-hydroxy-pyrimidine-5-acetamides |
US5378825A (en) * | 1990-07-27 | 1995-01-03 | Isis Pharmaceuticals, Inc. | Backbone modified oligonucleotide analogs |
US5223618A (en) * | 1990-08-13 | 1993-06-29 | Isis Pharmaceuticals, Inc. | 4'-desmethyl nucleoside analog compounds |
CA2100863A1 (en) * | 1991-01-23 | 1992-07-24 | David A. Bullough | Adenosine kinase inhibitors |
EP0521463A3 (en) * | 1991-07-04 | 1993-04-14 | Hoechst Aktiengesellschaft | Substituted cyclic cycloalkyltriols, process, intermediates for their preparation and their use as antiviral and antiparasitic agents |
AU4845193A (en) * | 1992-09-11 | 1994-04-12 | Regents Of The University Of California, The | Adenosine analogues and method of increasing adenosine release |
DK0674641T3 (da) * | 1992-12-17 | 1999-09-27 | Pfizer | Pyrrolopyrimidiner som CRF-antagonister |
IL108523A0 (en) * | 1993-02-03 | 1994-05-30 | Gensia Inc | Pharmaceutical compositions containing adenosine kinase inhibitors for preventing or treating conditions involving inflammatory responses and pain |
WO1994018215A1 (en) * | 1993-02-03 | 1994-08-18 | Gensia, Inc. | Adenosine kinase inhibitors comprising lyxofuranosyl derivatives |
-
1996
- 1996-06-04 US US08/651,882 patent/US6143749A/en not_active Expired - Fee Related
- 1996-06-06 CA CA002220006A patent/CA2220006A1/en not_active Abandoned
- 1996-06-06 WO PCT/US1996/009042 patent/WO1996040686A1/en active IP Right Grant
- 1996-06-06 JP JP9501456A patent/JP2000501694A/ja active Pending
- 1996-06-06 EP EP96918151A patent/EP0873340B1/de not_active Expired - Lifetime
- 1996-06-06 ES ES96918151T patent/ES2168479T3/es not_active Expired - Lifetime
- 1996-06-06 DE DE69617273T patent/DE69617273T2/de not_active Expired - Fee Related
- 1996-06-06 PT PT96918151T patent/PT873340E/pt unknown
- 1996-06-06 DK DK96918151T patent/DK0873340T3/da active
- 1996-06-06 AT AT96918151T patent/ATE209206T1/de not_active IP Right Cessation
-
1997
- 1997-12-05 MX MX9709718A patent/MX9709718A/es unknown
Also Published As
Publication number | Publication date |
---|---|
US6143749A (en) | 2000-11-07 |
CA2220006A1 (en) | 1996-12-19 |
EP0873340B1 (de) | 2001-11-21 |
MX9709718A (es) | 1998-07-31 |
DE69617273T2 (de) | 2002-07-25 |
PT873340E (pt) | 2002-05-31 |
DK0873340T3 (da) | 2002-05-21 |
ES2168479T3 (es) | 2002-06-16 |
WO1996040686A1 (en) | 1996-12-19 |
EP0873340A1 (de) | 1998-10-28 |
JP2000501694A (ja) | 2000-02-15 |
DE69617273D1 (de) | 2002-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE209206T1 (de) | Heterocyclisch substituierte cyclopentanderivate. | |
ATE267200T1 (de) | Bicyclische kinase inhibitoren | |
ID27535A (id) | Turunan pirasola sebagai inhibitor p-38 map kinase | |
FI941580A0 (fi) | Bisyklisiä ansamysiinejä | |
MX9707431A (es) | Inhibidores de la proteina cinasa c. | |
DK0657458T3 (da) | Inhibitorer af proteinkinase-C | |
MY118068A (en) | Protein kinase c inhibitor | |
ES2175624T3 (es) | Derivados de pirazolo(4,3-d)pirimidina y composiciones farmaceuticas que los contienen. | |
EA199900373A2 (ru) | Фармацевтические композиции | |
ATE214928T1 (de) | Thrombininhibitoren | |
TR199900049T2 (xx) | Protein tirozin kinaz inhibit�rleri olarak bisiklik heteroaromatik bile�ikler. | |
DE60142921D1 (de) | Azaphenanthridone-derivate und deren verwendung als parp-inhibitoren | |
DK0705100T3 (da) | Terapeutiske substituerede guanidiner | |
TR200101756T2 (tr) | Protein kinaz inhibitörleri olarak 4,5-pirazinoksindoller. | |
DE60112742D1 (de) | Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit | |
GEP20084346B (en) | Protein kinase c inhibitors | |
ES2088128T3 (es) | Aminosulfonilureas inhibidoras de acat. | |
AR028186A1 (es) | Compuestos de 5-aril-1, 2, 4-triazol inhibidores de ciclooxigenasa-2 y composiciones farmaceuticas que comprenden dichos compuestos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |